Cargando…
The Role of Preclinical Models in Creatine Transporter Deficiency: Neurobiological Mechanisms, Biomarkers and Therapeutic Development
Creatine (Cr) Transporter Deficiency (CTD) is an X-linked metabolic disorder, mostly caused by missense mutations in the SLC6A8 gene and presenting with intellectual disability, autistic behavior, and epilepsy. There is no effective treatment for CTD and patients need lifelong assistance. Thus, the...
Autores principales: | Ghirardini, Elsa, Calugi, Francesco, Sagona, Giulia, Di Vetta, Federica, Palma, Martina, Battini, Roberta, Cioni, Giovanni, Pizzorusso, Tommaso, Baroncelli, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392480/ https://www.ncbi.nlm.nih.gov/pubmed/34440297 http://dx.doi.org/10.3390/genes12081123 |
Ejemplares similares
-
Novel translational phenotypes and biomarkers for creatine transporter deficiency
por: Mazziotti, Raffaele, et al.
Publicado: (2020) -
Cell-specific vulnerability to metabolic failure: the crucial role of parvalbumin expressing neurons in creatine transporter deficiency
por: Ghirardini, Elsa, et al.
Publicado: (2023) -
Cyclocreatine treatment ameliorates the cognitive, autistic and epileptic phenotype in a mouse model of Creatine Transporter Deficiency
por: Cacciante, Francesco, et al.
Publicado: (2020) -
A novel mouse model of creatine transporter deficiency
por: Baroncelli, Laura, et al.
Publicado: (2014) -
A Nervous System-Specific Model of Creatine Transporter Deficiency Recapitulates the Cognitive Endophenotype of the Disease: a Longitudinal Study
por: Molinaro, Angelo, et al.
Publicado: (2019)